Smith & Nephew : Strong top line momentum moves up revenue guidance
>Beat on the top line, miss on consensus’ expectations on bottom line - Smith & Nephew’s Q2 revenues of $ 1,379m (+6.7% y-o-y) were 3%/1% compared to ODDO BHF/consensus. The underlying growth in the quarter was 7.8% vs our 5.2% and consensus’ 5.9%. There was no external growth effect, but the forex environment created a headwind of 120bp. H1 trading profit reached $ 417m (margin 15.3%, -5.2% y-o-y), which was in line with our forecast but 6% below consensus. EPS was $...Smith & Nephew is a global medical devices business operating in the markets for advanced surgical devices comprising orthopaedic reconstruction and trauma, sports medicine and advanced wound management. Co.'s advanced medical products and services include: Orthopaedic Reconstruction and Trauma (joint replacement systems for knees and hips and products to help repair broken bones); Advanced Wound Management (treatment and prevention products for hard-to-heal wounds); and Sports Medicine (implants and enabling technologies for minimally invasive repair of the joint).
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.